FIELD: medicinal virology. SUBSTANCE: vaccine strain is obtained from the living intranasal vaccine for adult corresponding to actual virus A/Shang-Dongh/9/93 (H3N2) by antigenic properties. Vaccine strain-reassortant is obtained by crossing epidemic virus A/Shang-Dongh/9/93 (H3N2) with cold-adopted temperature-sensitive virus A/Leningrad/134/17/57 (H2N2) - attenuation donor that is harmless for adult and children. Strain is deposited in Collection GISK at N 132. Strain is actively multiplicated in developing chicken embryos. Strain A/17/Shang-Dongh/93/3/5 (H3N2) is nonreactive for adult (age is 18-20 years) at intranasal administration. EFFECT: preparing the strain indicated above. 1 tbl
Authors
Dates
1997-04-20—Published
1994-12-29—Filed